Meagan Gray

730 total citations
29 papers, 490 citations indexed

About

Meagan Gray is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Meagan Gray has authored 29 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 13 papers in Hepatology and 8 papers in Surgery. Recurrent topics in Meagan Gray's work include Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (8 papers) and Liver Diseases and Immunity (5 papers). Meagan Gray is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (8 papers) and Liver Diseases and Immunity (5 papers). Meagan Gray collaborates with scholars based in United States. Meagan Gray's co-authors include Brendan M. McGuire, Mohamed Shoreibah, Omar Massoud, Lingchong You, Stephen Payne, Hao Song, Rohit Loomba, Theresa Hydes, Sujan Ravi and Kimberly A. Forde and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Meagan Gray

24 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meagan Gray United States 9 277 220 98 84 68 29 490
Arianna Ferro Italy 13 134 0.5× 100 0.5× 238 2.4× 101 1.2× 33 0.5× 31 542
Chien‐An Sun Taiwan 10 234 0.8× 101 0.5× 211 2.2× 34 0.4× 38 0.6× 13 470
Ahmed Eid Israel 9 156 0.6× 200 0.9× 56 0.6× 77 0.9× 11 0.2× 22 433
A. Ido Japan 11 128 0.5× 81 0.4× 94 1.0× 45 0.5× 20 0.3× 18 357
Yiran Wei China 11 182 0.7× 148 0.7× 77 0.8× 100 1.2× 8 0.1× 27 393
Klára Werling Hungary 9 154 0.6× 115 0.5× 59 0.6× 94 1.1× 17 0.3× 43 315
Koji Yamashita Japan 10 152 0.5× 119 0.5× 30 0.3× 27 0.3× 27 0.4× 40 330
Antonella Carbone Italy 10 73 0.3× 57 0.3× 71 0.7× 59 0.7× 133 2.0× 16 336
Luz Helena Gutierrez Sanchez United States 11 122 0.4× 47 0.2× 114 1.2× 217 2.6× 23 0.3× 22 450
Katsumoto Kato Japan 12 92 0.3× 109 0.5× 38 0.4× 138 1.6× 22 0.3× 30 345

Countries citing papers authored by Meagan Gray

Since Specialization
Citations

This map shows the geographic impact of Meagan Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meagan Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meagan Gray more than expected).

Fields of papers citing papers by Meagan Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meagan Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meagan Gray. The network helps show where Meagan Gray may publish in the future.

Co-authorship network of co-authors of Meagan Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Meagan Gray. A scholar is included among the top collaborators of Meagan Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meagan Gray. Meagan Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alkhouri, Naim, Michael Charlton, Meagan Gray, & Mazen Noureddin. (2025). The pleiotropic effects of glucagon-like peptide-1 receptor agonists in patients with metabolic dysfunction-associated steatohepatitis: a review for gastroenterologists. Expert Opinion on Investigational Drugs. 34(3). 169–195. 8 indexed citations
2.
Olson, Kristin M., et al.. (2024). S4427 Drug-Induced Autoimmune-Like Hepatitis and Stevens Johnsons Syndrome Secondary to Levetiracetam. The American Journal of Gastroenterology. 119(10S). S2829–S2830.
3.
Gray, Meagan, et al.. (2024). Metabolic characteristics of patients with MetALD: Caveats of a new definition. Liver International. 44(11). 2929–2938. 14 indexed citations
4.
Chapman, Malcolm, et al.. (2024). S4320 The Last Resort: A Case of Relapsing Autoimmune Hepatitis Responsive to Cyclophosphamide Salvage Therapy. The American Journal of Gastroenterology. 119(10S). S2776–S2776.
5.
Shoreibah, Mohamed, et al.. (2023). Metabolic dysfunction associated steatotic liver disease: Current practice, screening guidelines and management in the primary care setting. The American Journal of the Medical Sciences. 367(2). 77–88. 8 indexed citations
6.
7.
Bril, Fernando & Meagan Gray. (2023). Noninvasive tests to identify liver fibrosis in metabolic dysfunction‐associated steatotic liver disease are affected by race. Obesity. 32(3). 612–622. 8 indexed citations
8.
Axley, Page, et al.. (2023). Levetiracetam Liver Injury: A Benign Antiepileptic Agent?. ACG Case Reports Journal. 10(3). e01003–e01003. 2 indexed citations
9.
Bril, Fernando, Eddison Godinez Leiva, Romina Lomonaco, et al.. (2022). Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patients. PubMed. 2(2). 11–11. 5 indexed citations
10.
Bril, Fernando, Michael J. McPhaul, Srilaxmi Kalavalapalli, et al.. (2021). Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes. The Journal of Clinical Endocrinology & Metabolism. 106(11). e4360–e4371. 11 indexed citations
11.
Sack, Jordan, et al.. (2021). Association of Terry Nails With Liver Cirrhosis. The American Journal of Gastroenterology. 116(12). 2455–2458. 3 indexed citations
12.
Hydes, Theresa, Sujan Ravi, Rohit Loomba, & Meagan Gray. (2020). Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH. Clinical and Molecular Hepatology. 26(4). 383–400. 62 indexed citations
13.
Lin, Chee Paul, et al.. (2020). Su1695 NAFLD FIBROSIS SCORE OUTPERFORMS FIB-4 AND APRI IN PREDICTING ADVANCED FIBROSIS IN NON-NAFLD ETIOLOGIES OF LIVER DISEASE. Gastroenterology. 158(6). S–1384. 1 indexed citations
14.
Gray, Meagan, et al.. (2020). S2441 Acute Liver Failure Due to Toxoplasmosis After Orthotopic Liver Transplantation. The American Journal of Gastroenterology. 115(1). S1293–S1293. 1 indexed citations
15.
Gray, Meagan, et al.. (2019). Hepatocellular carcinoma surveillance: An evidence-based approach. World Journal of Gastroenterology. 25(13). 1550–1559. 157 indexed citations
16.
Gray, Meagan, et al.. (2019). Drug-Induced Liver Injury in the Setting of Chronic Liver Disease. Clinics in Liver Disease. 24(1). 89–106. 11 indexed citations
17.
Gray, Meagan, et al.. (2017). Portal Vein Thrombosis After Percutaneous Liver Biopsy. Clinical Gastroenterology and Hepatology. 16(1). e5–e6. 1 indexed citations
18.
19.
Gray, Meagan, Andrew Brock, & Nilesh Lodhia. (2013). Gastric Mucosal Calcinosis: A Rare Cause of Bleeding. Clinical Gastroenterology and Hepatology. 12(3). A22–A22. 2 indexed citations
20.
Song, Hao, Stephen Payne, Meagan Gray, & Lingchong You. (2009). Spatiotemporal modulation of biodiversity in a synthetic chemical-mediated ecosystem. Nature Chemical Biology. 5(12). 929–935. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arianna Ferro Breakdown of academic impact, for papers by Chien‐An Sun Breakdown of academic impact, for papers by Ahmed Eid Breakdown of academic impact, for papers by A. Ido Breakdown of academic impact, for papers by Yiran Wei Breakdown of academic impact, for papers by Klára Werling Breakdown of academic impact, for papers by Koji Yamashita Breakdown of academic impact, for papers by Antonella Carbone Breakdown of academic impact, for papers by Luz Helena Gutierrez Sanchez Breakdown of academic impact, for papers by Katsumoto Kato
Rankless by CCL
2026